BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $158B
1-Year Est. Return 28.56%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
+$29.8B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5,168
New
Increased
Reduced
Closed

Top Buys

1 +$2.84B
2 +$1.98B
3 +$1.94B
4
AMZN icon
Amazon
AMZN
+$1.5B
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.22B

Sector Composition

1 Technology 28.74%
2 Consumer Discretionary 11.24%
3 Financials 10.44%
4 Healthcare 9.19%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
4601
Cue Biopharma
CUE
$27M
$127 ﹤0.01%
415
-275
PIII icon
4602
P3 Health Partners
PIII
$8.68M
$126 ﹤0.01%
36
-44
FEAM icon
4603
5E Advanced Materials
FEAM
$80.5M
$125 ﹤0.01%
41
-97
CALC icon
4604
CalciMedica
CALC
$8.99M
$125 ﹤0.01%
19
LIDR icon
4605
AEye
LIDR
$74.3M
$121 ﹤0.01%
66
-66
PRPL icon
4606
Purple Innovation
PRPL
$76.7M
$120 ﹤0.01%
174
-965
LSF icon
4607
Laird Superfood
LSF
$28M
$115 ﹤0.01%
52
CASI
4608
DELISTED
CASI Pharmaceuticals
CASI
$114 ﹤0.01%
134
URG
4609
Ur-Energy
URG
$591M
$114 ﹤0.01%
82
SGMO icon
4610
Sangamo Therapeutics
SGMO
$147M
$112 ﹤0.01%
266
-180
CELU icon
4611
Celularity
CELU
$33.5M
$110 ﹤0.01%
99
EWM icon
4612
iShares MSCI Malaysia ETF
EWM
$376M
$109 ﹤0.01%
4
BATL icon
4613
Battalion Oil
BATL
$306M
$108 ﹤0.01%
96
ECOR icon
4614
electroCore
ECOR
$60.8M
$108 ﹤0.01%
24
-111
DRIO icon
4615
DarioHealth
DRIO
$69.6M
$102 ﹤0.01%
9
UFI icon
4616
UNIFI
UFI
$72.5M
$102 ﹤0.01%
29
-17
FCUV icon
4617
Focus Universal
FCUV
$4.69M
$100 ﹤0.01%
12
BTE icon
4618
Baytex Energy
BTE
$3.06B
$97 ﹤0.01%
30
NNBR icon
4619
NN Inc
NNBR
$76.8M
$96 ﹤0.01%
75
SNSE icon
4620
Sensei Biotherapeutics
SNSE
$39.7M
$96 ﹤0.01%
9
QTOP
4621
iShares Nasdaq Top 30 Stocks ETF
QTOP
$245M
$96 ﹤0.01%
+3
ONCT
4622
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$96 ﹤0.01%
+182
VELO
4623
Velo3D Inc
VELO
$302M
$96 ﹤0.01%
7
-89
CLST icon
4624
Catalyst Bancorp
CLST
$67.8M
$94 ﹤0.01%
6
SPRO icon
4625
Spero Therapeutics
SPRO
$129M
$93 ﹤0.01%
40